NIHR Alert: First-line chemotherapy for ovarian cancer given once every three weeks may preserve quality of life

Expert commentary is provided for a study in 1,438 patients with ovarian cancer which found those given weekly treatment reported a lower quality of life than those given treatment every 3 weeks. However a separate Japanese study found weekly chemotherapy improved survival.

Source:

NIHR Dissemination Centre